If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

Prescription drug spending in the United States rose by 10.2% last year, thanks in part to the popularity of GLP weight-loss ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

Despite being a drug designed to treat diabetes, some celebs have found success using Ozempic for weight loss purposes.

Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

These headaches are typically a result of how the drug interacts with your body, not a direct effect of the medication.

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...